Anca Prica

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Neoadjuvant Chemotherapy

Acute Lymphoblastic Leukemia

Diffuse Large B Cell Lymphoma

Top Venues

British journal of haematology

Clinical cancer research : an official journal of the American Association for Cancer Research

Bone marrow transplantation

This page only lists publications with an associated author ORCID identifier.

Publications

John G Kuruvilla, Christopher Rushton, Diego R Villa, Muhammad Aslam, Anca Prica, Nizar Abdel Samad, Stephane Doucet, Jill Dudebout, Isabelle Fleury, Graeme Fraser, Jean-Francois Larouche, Mona Shafey, Pamela Skrabek, Tanya Skamene, Ryan D Morin, Miguel Alcaide, Susana Ben-Neriah, David Lee, Chad Winch, Lois E Shepherd, David W Scott, Michael Crump, Bingshu E Chen, Annette E Hay
A randomized trial of ibrutinib and R-GDP prior to stem cell transplant in relapsed diffuse large B-cell lymphoma. British journal of haematology (2024)
Inna Y Gong, Anca Prica, Zharmaine Ante, Andrew Calzavara, Monika K Krzyzanowska, Simron Singh, Adam Suleman, Matthew C Cheung, Michael Crump
Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada. British journal of haematology (2023)
Julio C Chavez, Francine M Foss, Basem M William, Jonathan E Brammer, Sonali M Smith, Anca Prica, Jasmine M Zain, Joseph M Tuscano, Harsh R Shah, Neha Mehta-Shah, Praveen Ramakrishnan Ramakrishnan Geethakumari, Ben X Wang, Stephanie Zantinge, Lisa Wang, Ling Zhang, Anmarie Boutrin, Weiguang Zhao, Lily I Cheng, Nathan Standifer, Lisa Hewitt, Enowmpey Enowtambong, Weiping Shao, Shringi Sharma, Gianluca Carlesso, Jeffrey A Moscow, Lillian L Siu
Targeting the Inducible T-cell Costimulator (ICOS) in patients with Relapsed/Refractory T-Follicular Helper Phenotype Peripheral T-Cell and Angioimmunoblastic T-Cell Lymphoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Adam Suleman, Suriya J Aktar, Zharmaine Ante, Ning Liu, Kelvin Kar-Wing Chan, Matthew C Cheung, Anca Prica
Outcomes of patients with indolent lymphoma treated with bendamustine plus rituximab compared to rituximab plus CVP or CHOP chemoimmunotherapy in Ontario. British journal of haematology (2023)
Abi Vijenthira, John Kuruvilla, Anca Prica
Cost-effectiveness analysis of allogeneic versus autologous stem cell transplant versus chemo-immunotherapy for early relapse of follicular lymphoma within 2 years of initial therapy. Bone marrow transplantation 56 (10) (2021)